An international survey of women with metastatic breast cancer conducted to evaluate their perceptions of quality of life and what additional medical information and support was needed to help them uncovered an unexpected finding. At a time when patients with incurable cancer are needed to participate in clinical trials, the majority of these women were never advised about any breast cancer…
At ECR 2010 in Vienna, Sectra focus on solutions for increased productivity. Sectra RIS/PACS is a performance solution for wide area radiology. Built on the latest Sectra RapidConnectTM technology, it allows radiologists to work from any location that offers reasonable Internet access and to share images and information between multiple locations with ease.
Digital mammograms deliver an average of 22% less radiation than film mammograms, according to a study partially funded by the National Cancer Institute and published in the American Journal of Roentgenology, Reuters reports. For the study, researchers analyzed the results of the 2005 Digital Mammographic Imaging Screening Trial involving 49,528 women. That trial found that digital mammograms…
New research on deaths from cancer in Europe concludes that the key priority for continuing to reduce mortality is cutting tobacco smoking. The study shows that, while deaths for men from lung cancer in the EU have declined overall, by 17 % from 1995 to 2004, they rose by 27% for women over the same period. It also reveals other significant differences in the mortality between different EU…
More women die of breast cancer in areas where mammography centers are few and far between, according to research by a Medical College of Georgia radiology resident. Breast cancer mortality rates ranged from 34.1 per 100,000 women in counties with no mammography facilities to 27.5 in those with at least one, said Dr. Kandace Klein, a fourth-year radiology resident.
Breast and cervical cancer together account for more than one quarter of all female cancer deaths worldwide, with the majority – including more than 85 % of all cervical cancer deaths – occurring in developing countries. However, a small number of highly effective programs demonstrate that much can be done to reduce risk and increase sustainable access to diagnosis and treatment for these…
Members of a Syracuse University research team in the USA have shown that an obscure phenomenon called stochastic resonance (SR) can improve the clarity of signals in systems such as radar, sonar and even radiography, used in medical clinics to detect signs of breast cancer. It does this by adding carefully selected noise to the system.
Brain tumors are the primary cause of cancer mortality in children. Even if a cure is possible, young patients often suffer tremendously from the stressful treatment which can be harmful to the developing brain. Therefore, there is an urgent need for target-oriented, gentle treatment methods. The most important childhood brain tumors are medulloblastoma, which is diagnosed in approximately one…
Targeted breast ultrasound of suspicious areas of the breast, including lumps, is a safe, reliable and cost-effective alternative to invasive biopsies for women under age 40, according to the findings of two new studies presented.
Scientists are closer to discovering why some people respond to breast cancer radiotherapy better than others, according to Breast Cancer Campaign. Dr Laura Smith, at the Leeds Institute of Molecular Medicine, University of Leeds, has been awarded a pilot grant by Breast Cancer Campaign, to study why some types of breast cancers are difficult to destroy with radiotherapy.
Elastography is an effective, convenient technique that, when added to breast ultrasound, helps distinguish cancerous breast lesions from benign results, according to an ongoing study presented today at the annual meeting of the Radiological Society of North America (RSNA).
At RSNA 2009, Sectra launches a new breast imaging PACS workstation built on Sectra RapidConnect technology. With this next-generation mammography workstation, Sectra focuses on customer productivity and wide area radiology.
At RSNA 2009, GE Healthcare is presenting a big basket filled with trends and innovations for the radiology department:
At RSNA 2009 in Chicago, Sectra focus on solutions for increased productivity. Sectra RIS/PACS is a performance solution for wide area radiology. Built on the Sectra RapidConnect technology it enables efficient workload sharing across multiple sites, even for large image stacks over strained networks. This way, Sectra RIS/PACS provides the opportunity to cope with ever-expanding challenges such…
Cancer imaging is one of the most promising medical fields. Hybrid technologies, such as PET/CT or future MRI/PET, are the tools radiologists and oncologists use to gain ever deeper insights into the biological characteristics of tumours. During the Medica Congress the Integrated diagnostics and therapy in oncology imaging session (Thursday 19 November) innovative tools and related developments…
French expert Dr Jacques Souquet PhD, President of SuperSonic Imagine, describes the value and potential of ShearWave elastography, the latest development in ultrasound that enables radiologists to acquire user independent information about tissue stiffness by measuring both, ultrasound and shear waves.
The Innovation Prize for outstanding, application-oriented ideas in life sciences has been awarded by the Working Group of BioRegions at the Biotechnica in Hanover to research groups from Heidelberg, Munich and Ulm. Professor Lisa Wiesmüller, of the Women’s Hospital, University of Ulm, received the €2,000 prize for developing a test system for the identification and early detection of breast…
Professor Roger Tsien, Nobel Laureate in Chemistry 2008 for the ‘Discovery and Development of Green Fluorescent Proteins’, was one three* Keynote Speakers at the opening ceremony of the Medical Physics and Bioengineering World Congress 2009, held in Munich this September.
Philips has developed a proprietary technology for elastography that uses new strain analytics for signals captured on the IU22 volume linear transducer and yields a relative quantification of tissue stiffness, which is presented as statistical charts displayed alongside a colour-coded qualificative image superimposed on the B-mode screen.
Advances in cancer prevention and treatment reported at this week´s premier European congress for specialists in gynaecological cancers show that care is being more effectively tailored to the needs of individual women, so that survival can be improved without the cost of added complications and reduced quality of life.
In addition to being Breast Cancer Awareness Month, this October is the tenth anniversary of digital mammography, a technology introduced by GE Healthcare in 1999. Similar to digital photography, digital mammography replaces the film used in traditional mammography with digital files viewed and stored on computers.
The first joint congress ECCO 15 - ESMO 34 of the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO) is taking place this week in Berlin. It is the only congress in Europe that covers the entire spectrum of cancer from basic science and translational research, to prevention, treatment, nursing and supportive care for all types of tumours.
A new initiative designed to inform and educate policymakers at national, European, and global level about the needs of the oncology community was launched at Europe's largest cancer congress, ECCO 15 — ESMO 34, in Berlin. The European Academy of Cancer Sciences will help to keep the interests of cancer patients at the forefront of the policy agenda, and avoid policy decisions that had a…
Removal of the primary breast tumour in women whose cancer has already spread to other parts of the body can have a significant effect on their survival, Dutch researchers have found. Their research meant that women who were diagnosed at a late stage of the disease could expect to survive longer. They discovered that those patients who had received surgery survived for considerably longer than…
Researchers around the globe are studying whether a genomic test, developed with micro-array technology, is superior to traditional methods in assessing aggressive breast cancer, and therefore could spare a considerable percentage of women from the onslaught of chemotherapy The Breast International Group (BIG) in Brussels, Belgium, manages TRANSBIG, an international network created to avoid…